Literature DB >> 4266407

Serum gold. II. Levels in rheumatoid arthritis.

H M Rubinstein, A A Dietz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4266407      PMCID: PMC1006062          DOI: 10.1136/ard.32.2.128

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Serum gold. I. Estimation by atomic absorption spectroscopy.

Authors:  A A Dietz; H M Rubinstein
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

2.  Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.

Authors:  A Lorber; R L Cohen; C C Chang; H E Anderson
Journal:  Arthritis Rheum       Date:  1968-04

3.  Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis.

Authors:  F E Krusius; A Markkanen; P Peltola
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

4.  Gold nephropathy. A clinical and pathologic study.

Authors:  D S Silverberg; E G Kidd; T K Shnitka; R A Ulan
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec
  4 in total
  22 in total

1.  Binding of sodium aurothiomalate to human serum albumin in vitro at physiological conditions.

Authors:  S M Pedersen
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

2.  Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity.

Authors:  A E Koch; J C Burrows; P J Polverini; M Cho; S J Leibovich
Journal:  Agents Actions       Date:  1991-11

Review 3.  Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors:  M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

4.  Inhibition of neutrophil migration by sera from patients with rheumatoid arthritis.

Authors:  A S Kemp; P Roberts-Thomson; S H Neoh; S Brown
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

5.  Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.

Authors:  S R Rudge; D Perrett; A J Swannell
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

6.  Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).

Authors:  D E Furst; S H Dromgoole
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

7.  Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole.

Authors:  A G Mowat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

8.  Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors:  K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

9.  Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds.

Authors:  P E Lipsky; M Ziff
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

10.  A comparison of the effects of two gold-containing therapeutic agents on articular chondrocyte growth in vitro.

Authors:  C J Kirkpatrick; W Mohr
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.